The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 28.50
Low: 28.50
Prev. Close: 28.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

1 Oct 2015 15:38

RNS Number : 9796A
Ilika plc
01 October 2015
 

 

Ilika plc

("Ilika" or the "Company")

 

Grant of Options, Conversion of Preference Shares & Total Voting Rights

 

Ilika (AIM: IKA), the accelerated materials innovation company, announces that, following the passing of resolutions 6 and 7 at yesterday's Annual General Meeting ("AGM"), Ilika yesterday granted options over 160,000 ordinary shares of 1p each in the Company ("Options") to non-executive directors at an exercise price of 68.75 pence per share, being the closing mid-market price on 29 September 2015. Nominal value options over 1,674,908 ordinary shares of 1p each in the Company have been granted to executive directors.

 

The Options represent in aggregate 2.79 per cent of the existing issued share capital.

 

In addition, the Company announces that 50,000 Convertible Preference Shares have today been converted into Ordinary Shares of 1p each in the Company ("Ordinary Shares") on the basis of 1 new Ordinary Share for every 1 Convertible Preference Share. The Company has today applied for admission to trading on AIM ("Admission") of those 50,000 new Ordinary Shares. Admission is expected to occur on 7 October 2015.

 

The new Ordinary Shares rank pari passu with the Company's existing issued Ordinary Shares. Following this conversion the figure of 65,786,416 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Details of the Options

 

The following unapproved share options were issued to Directors with each award vesting on the achievement of certain performance targets over a three-year period (details of which were provided in the Notice of AGM):

 

Director

Number of options granted

Total number of Options now held

Per cent. of current issued share capital

Mike Inglis

120,000

120,000

0.182%

Keith Jackson

40,000

40,000

0.061%

 

The following options were issued under the Company's recently approved Long Term Incentive Plan 2015 with each award vesting on the achievement of certain performance targets over a three-year period (details of which were provided in the Notice of AGM, Appendix 1):

 

Director

Number of options granted

Total number of Options now held

Per cent. of current issued share capital

Graeme Purdy

872,727

2,330,727

3.543%

Brian Hayden

527,272

1,289,472

1.960%

Steve Boydell

274,909

637,109

0.968%

 

Graeme Purdy holds 589,427 Ordinary shares representing 0.896% of current issued share capital and Steve Boydell holds 9,090 Ordinary shares representing 0.014% of current issued share capital. Brian Hayden holds 426,300 Preference Shares.

 

The Notice of AGM can be found here: http://www.ilika.com/images/uploads/general/AGM_notice_final.pdf

 

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan / James Black / Paul Gillam

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZFLFBEBFXFBD
Date   Source Headline
13th May 202410:16 amRNSPosting of Circular & Notice of General Meeting
10th May 20243:02 pmRNSResult of Placing
10th May 20247:00 amRNSProposed Placing and Open Offer & Notice of GM
26th Apr 20247:00 amRNSAgratas joins Goliath industrialisation programme
23rd Apr 20247:00 amRNSCapital Markets Day and Trading Update
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.